These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15286068)

  • 41. Two-year prospective case-controlled study of a case management program for community-dwelling individuals with schizophrenia.
    Chen M; Wu G; Wang Z; Yan J; Zhou J; Ding Y; Jiang Y; Rao S; Zhou Q; Ni H; Zhao J; Su Y; Hu J; Zhang Y; Yi Z; Yang W; Song L
    Shanghai Arch Psychiatry; 2014 Jun; 26(3):119-28. PubMed ID: 25114486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing educational effectiveness: the impact of a specialist course on the delivery of care.
    Jordan S; Coleman M; Hardy B; Hughes D
    J Adv Nurs; 1999 Oct; 30(4):796-807. PubMed ID: 10520091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of cognitive-behavioural intervention by mental health nurses in schizophrenia.
    Alam F
    Br J Psychiatry; 2007 Mar; 190():271; author reply 271-2. PubMed ID: 17329754
    [No Abstract]   [Full Text] [Related]  

  • 44. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial.
    Gray R; Leese M; Bindman J; Becker T; Burti L; David A; Gournay K; Kikkert M; Koeter M; Puschner B; Schene A; Thornicroft G; Tansella M
    Br J Psychiatry; 2006 Dec; 189():508-14. PubMed ID: 17139034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuing education meetings and workshops: effects on professional practice and healthcare outcomes.
    Forsetlund L; O'Brien MA; Forsén L; Reinar LM; Okwen MP; Horsley T; Rose CJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD003030. PubMed ID: 34523128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study protocol for a feasibility trial of telephone-delivered Adherence Therapy for adults with type 2 diabetes.
    Alenazi F; Peddle M; Bressington D; Mahzari M; Gray R
    Nurs Open; 2021 May; 8(3):1510-1519. PubMed ID: 33471963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study.
    Zimmer A; Coslovsky M; Abraham I; Décard BF
    Patient Prefer Adherence; 2017; 11():1815-1830. PubMed ID: 29118575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey.
    Emsley R; Alptekin K; Azorin JM; Cañas F; Dubois V; Gorwood P; Haddad PM; Naber D; Olivares JM; Papageorgiou G; Roca M; Thomas P; Hargarter L; Schreiner A;
    Ther Adv Psychopharmacol; 2015 Dec; 5(6):339-50. PubMed ID: 26834967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Qualitative evaluation of adherence therapy in Parkinson's disease: a multidirectional model.
    Daley DJ; Deane KH; Gray RJ; Hill R; Myint PK
    Patient Prefer Adherence; 2015; 9():989-98. PubMed ID: 26203231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial.
    Skarsholm H; Stoevring H; Nielsen B
    Schizophr Res Treatment; 2014; 2014():789403. PubMed ID: 24991433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of community treatments for schizophrenia and other psychotic disorders: a literature review.
    Armijo J; Méndez E; Morales R; Schilling S; Castro A; Alvarado R; Rojas G
    Front Psychiatry; 2013 Oct; 4():116. PubMed ID: 24130534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing non-adherence and the 3 Cs: collaboration, cash and coercion.
    David AS
    World Psychiatry; 2013 Oct; 12(3):229-30. PubMed ID: 24096782
    [No Abstract]   [Full Text] [Related]  

  • 54. The serious mental illness health improvement profile [HIP]: study protocol for a cluster randomised controlled trial.
    White J; Gray RJ; Swift L; Barton GR; Jones M
    Trials; 2011 Jul; 12():167. PubMed ID: 21726440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort.
    Brown S; Mitchell C
    Soc Psychiatry Psychiatr Epidemiol; 2012 Jun; 47(6):843-7. PubMed ID: 21559973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuing education meetings and workshops: effects on professional practice and health care outcomes.
    Forsetlund L; Bjørndal A; Rashidian A; Jamtvedt G; O'Brien MA; Wolf F; Davis D; Odgaard-Jensen J; Oxman AD
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003030. PubMed ID: 19370580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shared decision making and serious mental illness.
    Mahone IH
    Arch Psychiatr Nurs; 2008 Dec; 22(6):334-43. PubMed ID: 19026922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Training in dual diagnosis interventions (the COMO Study): randomised controlled trial.
    Hughes E; Wanigaratne S; Gournay K; Johnson S; Thornicroft G; Finch E; Marshall J; Smith N
    BMC Psychiatry; 2008 Feb; 8():12. PubMed ID: 18304310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining and assessing adherence to oral antipsychotics: a review of the literature.
    Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL
    Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medication decision-making by persons with serious mental illness.
    Mahone IH
    Arch Psychiatr Nurs; 2004 Aug; 18(4):126-34. PubMed ID: 15305278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.